The use of the antipsychotic medication Seroquel has been linked to an increased risk of diabetes, pancreatitis and death. Thousands of Seroquel lawsuits have been filed throughout the United States by individuals who suffered severe and life threatening injuries.
STATUS OF SEROQUEL LITIGATION: All federal Seroquel lawsuits have been consolidated in a Multidistrict Litigation centralized in the U.S. District Court for the Middle District of Florida. Seroquel settlement agreements have been reached in thousands of individual cases.
OVERVIEW: Seroquel, which is known generically as quetiapine fumarate, is an atypical antipsychotic medication which was approved by the FDA in 1997. It is approved for treatment of schizophrenia, but it is also commonly used off-label for treatment of anxiety, obsessive dementia, compulsive disorders and autism.
AstraZeneca has been accused of heavily marketing Seroquel for “off-label” uses which the FDA has not approved or determined to be safe and effective. Some experts have estimated that as much as 70% of all Seroquel prescriptions were for unapproved uses.
Seroquel has been used by more than 19 million people worldwide. It is one of the most profitable drugs for AstraZeneca, with annual sales of about $2.8 billion.
SEROQUEL DIABETES SIDE EFFECTS: Studies have confirmed that Seroquel side effects could increase the risk of weight gain, hyperglycemia and diabetes. While all of the drugs within the class of medications known as atypical antipsychotics have been linked to diabetes side effects, the risk was found to be highest with Seroquel.
Seroquel lawsuits have been pursued by individuals who have suffered any of the following side effects from the drug:
- Tardive Dyskinesia